Related Experiment Videos

Glycogen storage disease type II in Israel

N Bashan1, R Potashnik, V Barash

  • 1Department of Pediatrics, Ben-Gurion University of the Negev, Beer Sheva, Israel.

Israel Journal of Medical Sciences
|April 1, 1988
PubMed

Insights

Alpha-glucosidase deficiency, a rare genetic disorder, is prevalent in Israel

Area of Science:

  • Medical Genetics
  • Metabolic Disorders
  • Rare Diseases

Background:

  • Alpha-glucosidase deficiency, also known as Pompe disease, is a rare inherited metabolic disorder.
  • It is characterized by the deficiency of the enzyme acid alpha-glucosidase, leading to glycogen accumulation in cells.
  • This accumulation primarily affects muscle tissue, causing progressive muscle weakness and dysfunction.

Purpose of the Study:

  • To report the diagnosis and characteristics of alpha-glucosidase deficiency in Israel over 15 years.
  • To investigate the prevalence and clinical presentation of the disease in different ethnic groups.
  • To evaluate diagnostic methods and discuss implications for genetic counseling and prenatal diagnosis.

Main Methods:

  • Retrospective analysis of 18 diagnosed patients with alpha-glucosidase deficiency.
  • Clinical assessment, including disease type (infantile vs. juvenile).
  • Enzymatic assays of alpha-glucosidase activity in muscle and leukocytes, including pH profiles.

Main Results:

  • Eighteen patients diagnosed, predominantly Palestinian Arabs, with two from a Jewish Iraqi family.
  • Most patients presented with infantile Pompe disease; one had the juvenile type.
  • Muscle alpha-glucosidase activity was severely deficient (zero in 10/17 patients, <18% in others); leukocyte activity was variable and unreliable for diagnosis.
  • Significant heterogeneity in enzyme pH profiles observed.
  • High prevalence noted in the Arab population, despite low prevalence of other autosomal recessive diseases.

Conclusions:

  • Alpha-glucosidase deficiency shows a notable prevalence in the Arab population in Israel.
  • Muscle biopsy is a more reliable diagnostic indicator than leukocyte enzyme activity.
  • Prenatal diagnosis should be offered to families with a history of this severe genetic disorder.

Related Concept Videos